# FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia

> **NCT02392429** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **National Cancer Institute (NCI)** · enrollment: 87 (actual)

## Conditions studied

- Acute Myeloid Leukemia

## Interventions

- **PROCEDURE:** Biospecimen Collection
- **PROCEDURE:** Bone Marrow Aspiration
- **PROCEDURE:** Bone Marrow Biopsy
- **DRUG:** Chemotherapy
- **PROCEDURE:** Computed Tomography
- **DRUG:** Cytarabine
- **OTHER:** Fluorothymidine F-18
- **OTHER:** Laboratory Biomarker Analysis
- **PROCEDURE:** Positron Emission Tomography

## Key facts

- **NCT ID:** NCT02392429
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2016-04-20
- **Primary completion:** 2023-12-31
- **Final completion:** 2027-02-13
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02392429

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02392429, "FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02392429. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*